Page 181 - HIV/AIDS Guidelines
P. 181

Table 13. Antiretroviral Therapy-Associated Common and/or Severe Adverse Effects

 (See Appendix B for additional information listed by drug.)  (Page 4 of 4)




 Adverse Effects  NRTIs  NNRTIs   PIs                             INSTI                 EI


 Lipodystrophy  Lipoatrophy: Thymidine analogs (d4T > ZDV). May be  Lipohypertophy: Trunk fat increase observed with EFV-, PI-, and RAL-containing
 more likely when combined with EFV than with a  regimens; however, causal relationship has not been established.
 ritonavir-boosted PI.

 Myopathy/elevated creatine  ZDV: myopathy               RAL: ↑ CPK. muscle
 phosphokinase (CPK)                                     weakness and
                                                         rhabdomyolysis

 Nephrotoxicity/  TDF: ↑ serum creatinine, proteinuria,  IDV: ↑ serum creatinine, pyuria;
 urolithiasis  hypophosphatemia, urinary phosphate wasting,  hydronephrosis or renal atrophy
 glycosuria, hypokalemia, non-anion gap metabolic
                  IDV, ATV: Stone, crystal formation;
 acidosis
                  adequate hydration may reduce risk.
 Concurrent use of PI may increase risk.


 Osteopenia/  TDF: Associated with greater loss of BMD than ZDV,  Decreases in BMD observed in studies of regimens
 osteoporosis  d4T, and ABC.  containing different NRTIs combined with either NNRTIs or
 PIs.

 Peripheral neuropathy  Peripheral neuropathy (pain and/or paresthesias, lower
 extremities > upper extremities): d4T > ddI and ddC
 (can be irreversible)

 Rash  All NNRTIs  ATV, DRV, FPV                         RAL: Uncommon               MVC



 Stevens-Johnson syndrome  ddI, ZDV: Reported cases  NVP > DLV, EFV,  FPV, DRV, IDV, LPV/r, ATV: Reported  RAL
 (SJS)/ toxic epidermal  ETR, RPV  cases
 necrosis (TEN)

 Key to Abbreviations: 3TC = lamivudine, ABC = abacavir, ALT = alanine aminotransferase, ARV = antiretroviral, AST = aspartate aminotransferase, ATV = atazanavir, ATV/r = atazanavir + ritonavir, BMD = bone mineral
 density, CNS = central nervous system, CPK = creatine phosphokinase, CVD = cardiovascular disease, d4T = stavudine, ddC = zalcitabine, ddI = didanosine, DLV = delaviridine, DM = diabetes mellitus,
 DRV = darunavir, DRV/r = darunavir + ritonavir, ECG = electrocardiogram, EFV = efavirenz, EI = entry inhibitor, ETR = etravirine, FPV = fosamprenavir, FPV/r = fosamprenavir + ritonavir, FTC = emtricitabine,
 GI = gastrointestinal, HBV = hepatitis B virus, HDL = high-density lipoprotein, HSR = hypersensitivity reaction, IDV = indinavir, INSTI = integrase strand transfer inhibitor, LDL = low-density lipoprotein,
 LPV/r = lopinavir + ritonavir, MI = myocardial infarction, MVC = maraviroc, NFV = nelfinavir, NNRTI = non-nucleoside reverse transcriptase inhibitor, NRTI = nucleoside reverse transcriptase inhibitor,
 NVP = nevirapine, PI = protease inhibitor, PT = prothrombin time, RAL = raltegravir, RPV = rilpivirine, RTV = ritonavir, SJS = Stevens-Johnson syndrome, SQV = saquinavir, SQV/r = saquinavir + ritonavir,
 TDF = tenofovir, TEN = toxic epidermal necrosis, TG = triglyceride, TPV = tipranavir, TPV/r = tipranavir + ritonavir, ZDV = zidovudine











 Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents                                                                                                              K-11
 Downloaded from http://aidsinfo.nih.gov/guidelines on 12/8/2012 EST.
   176   177   178   179   180   181   182   183   184   185   186